TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis

Epithelial-mesenchymal transition (EMT) is associated with retinal pigment epithelium (RPE) dysfunction in degenerative retinal diseases. However, the role of partial EMT (pEMT), a hybrid state exhibiting both epithelial and mesenchymal markers, remains poorly understood in this context. Our previou...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Li, Yosuke Nagasaka, Hongtao Shen, Xinyu Zhou, Jianjie Ma, Dilza Trevisan-Silva, Nicholas E. Sherman, Jayakrishna Ambati, Bradley D. Gelfand, Lian-Wang Guo
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253125000149
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199438388264960
author Jing Li
Yosuke Nagasaka
Hongtao Shen
Xinyu Zhou
Jianjie Ma
Dilza Trevisan-Silva
Nicholas E. Sherman
Jayakrishna Ambati
Bradley D. Gelfand
Lian-Wang Guo
author_facet Jing Li
Yosuke Nagasaka
Hongtao Shen
Xinyu Zhou
Jianjie Ma
Dilza Trevisan-Silva
Nicholas E. Sherman
Jayakrishna Ambati
Bradley D. Gelfand
Lian-Wang Guo
author_sort Jing Li
collection DOAJ
description Epithelial-mesenchymal transition (EMT) is associated with retinal pigment epithelium (RPE) dysfunction in degenerative retinal diseases. However, the role of partial EMT (pEMT), a hybrid state exhibiting both epithelial and mesenchymal markers, remains poorly understood in this context. Our previous research demonstrated that TMEM97 ablation in mice worsens photoreceptor loss in an oxidant-induced RPE damage model. Here, we link TMEM97 to pEMT in RPE cells and explore the underlying molecular mechanisms. We found that re-expressing TMEM97 in the RPE of TMEM97-knockout mice, via subretinal lentiviral delivery, mitigated oxidant (NaIO3)-induced photoreceptor loss. Interestingly, TMEM97 knockout in ARPE19 cells in vitro led to upregulation of cadherin/adhesion-binding pathways, even without oxidant exposure. Integrated proteomic, transcriptomic, segmentation, and immunoblot analyses revealed that TMEM97 ablation induces pEMT, marked by the concurrent expression of epithelial E-cadherin and mesenchymal N-cadherin, a process reversed upon TMEM97 re-expression. Furthermore, TMEM97 negatively regulated CTNND2 protein (catenin δ-2), but not the known EMT driver β-catenin, and CTNND2 was found to promote ADAM10, which sustains both E- and N-cadherin protein levels. These findings identify TMEM97 as a novel regulator of RPE-cell pEMT through the CTNND2-ADAM10 axis, highlighting potential new targets for therapeutic intervention in RPE-related pathophysiology.
format Article
id doaj-art-9cd6ba77f5204a55991ba9d990ee59ed
institution Kabale University
issn 2162-2531
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj-art-9cd6ba77f5204a55991ba9d990ee59ed2025-02-08T05:00:10ZengElsevierMolecular Therapy: Nucleic Acids2162-25312025-03-01361102460TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axisJing Li0Yosuke Nagasaka1Hongtao Shen2Xinyu Zhou3Jianjie Ma4Dilza Trevisan-Silva5Nicholas E. Sherman6Jayakrishna Ambati7Bradley D. Gelfand8Lian-Wang Guo9Division of Surgical Sciences, Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Ophthalmology, University of Virginia, Charlottesville, VA 22903, USADivision of Surgical Sciences, Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22903, USADivision of Surgical Sciences, Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22903, USADivision of Surgical Sciences, Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22903, USASchool of Medicine Core Facilities, University of Virginia, Charlottesville, VA 22903, USASchool of Medicine Core Facilities, University of Virginia, Charlottesville, VA 22903, USADepartment of Ophthalmology, University of Virginia, Charlottesville, VA 22903, USADepartment of Ophthalmology, University of Virginia, Charlottesville, VA 22903, USA; Corresponding author: Bradley D. Gelfand, Department of Ophthalmology, University of Virginia, Charlottesville, VA 22903, USA.Division of Surgical Sciences, Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA; Department of Ophthalmology, University of Virginia, Charlottesville, VA 22903, USA; Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22903, USA; Corresponding author: Lian-Wang Guo, Department of Surgery, School of Medicine, University of Virginia, 409 Lane Road, Charlottesville, VA 22903, USA.Epithelial-mesenchymal transition (EMT) is associated with retinal pigment epithelium (RPE) dysfunction in degenerative retinal diseases. However, the role of partial EMT (pEMT), a hybrid state exhibiting both epithelial and mesenchymal markers, remains poorly understood in this context. Our previous research demonstrated that TMEM97 ablation in mice worsens photoreceptor loss in an oxidant-induced RPE damage model. Here, we link TMEM97 to pEMT in RPE cells and explore the underlying molecular mechanisms. We found that re-expressing TMEM97 in the RPE of TMEM97-knockout mice, via subretinal lentiviral delivery, mitigated oxidant (NaIO3)-induced photoreceptor loss. Interestingly, TMEM97 knockout in ARPE19 cells in vitro led to upregulation of cadherin/adhesion-binding pathways, even without oxidant exposure. Integrated proteomic, transcriptomic, segmentation, and immunoblot analyses revealed that TMEM97 ablation induces pEMT, marked by the concurrent expression of epithelial E-cadherin and mesenchymal N-cadherin, a process reversed upon TMEM97 re-expression. Furthermore, TMEM97 negatively regulated CTNND2 protein (catenin δ-2), but not the known EMT driver β-catenin, and CTNND2 was found to promote ADAM10, which sustains both E- and N-cadherin protein levels. These findings identify TMEM97 as a novel regulator of RPE-cell pEMT through the CTNND2-ADAM10 axis, highlighting potential new targets for therapeutic intervention in RPE-related pathophysiology.http://www.sciencedirect.com/science/article/pii/S2162253125000149MT: Oligonucleotides: Therapies and Applicationspartial EMTE-cadherinN-cadherinZO-1catenin
spellingShingle Jing Li
Yosuke Nagasaka
Hongtao Shen
Xinyu Zhou
Jianjie Ma
Dilza Trevisan-Silva
Nicholas E. Sherman
Jayakrishna Ambati
Bradley D. Gelfand
Lian-Wang Guo
TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis
Molecular Therapy: Nucleic Acids
MT: Oligonucleotides: Therapies and Applications
partial EMT
E-cadherin
N-cadherin
ZO-1
catenin
title TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis
title_full TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis
title_fullStr TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis
title_full_unstemmed TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis
title_short TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis
title_sort tmem97 governs partial epithelial mesenchymal transition of retinal pigment epithelial cells via the ctnnd2 adam10 axis
topic MT: Oligonucleotides: Therapies and Applications
partial EMT
E-cadherin
N-cadherin
ZO-1
catenin
url http://www.sciencedirect.com/science/article/pii/S2162253125000149
work_keys_str_mv AT jingli tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT yosukenagasaka tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT hongtaoshen tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT xinyuzhou tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT jianjiema tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT dilzatrevisansilva tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT nicholasesherman tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT jayakrishnaambati tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT bradleydgelfand tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis
AT lianwangguo tmem97governspartialepithelialmesenchymaltransitionofretinalpigmentepithelialcellsviathectnnd2adam10axis